Description
Entresto (sacubitril/valsartan) is a prescription medication used to treat heart failure with reduced ejection fraction (HFrEF). This innovative drug combines two active ingredients: sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin receptor blocker (ARB). By targeting different pathways involved in heart failure, Entresto helps to improve heart function, reduce symptoms, and decrease the risk of hospitalization related to heart failure.
The dual action of Entresto works by preventing the breakdown of natriuretic peptides, which play a crucial role in regulating blood pressure and fluid balance. At the same time, valsartan blocks the effects of angiotensin II, a hormone that causes blood vessels to constrict, leading to increased blood pressure and strain on the heart. This combination therapy effectively lowers blood pressure, reduces fluid retention, and ultimately improves the heart’s efficiency.